Renal Transplantation for Diabetic Nephropathy
Diabetes mellitus, in 1994, is the leading cause of end-stage renal disease (ESRD) in the United States (US), Japan, and most nations in industrialized Europe. All registries in Europe, Asia, and North America show that glomerulonephritis and hypertensive renal disease rank well below diabetes in frequency of diagnosis among new ESRD patients, substantiating Mauer and Chavers contention that »Diabetes is the most important cause of ESRD in the Western world «. The growth of both the total and diabetic population of ESRD patients in the US is depicted in figure 52-1. Data from 1990, the most recent calendar year report of the United States Renal Data System (USRDS), underscore this point. Of 165,363 patients — including 40,174 with diabetes (24.3%) — receiving either dialytic therapy or a kidney transplant in the US in 1990 — 45,153 developed ESRD during 1990 . There were 15,383 (34.0%) diabetics whose renal failure was attributed to diabetes in the new incidence group. Therefore, while the incidence of ESRD caused by diabetes is 62 per million out of a total for all diseases of 169 per million, the prevalence of diabetics among those undergoing ESRD treatment decreased to a smaller segment of the whole (152 per million out of a total of 618 per million).
KeywordsDiabetes Type Diabetic Nephropathy Renal Transplantation Kidney Transplant ESRD Patient
Unable to display preview. Download preview PDF.
- 2.U.S. Renal Data System. USRDS 1993 Annual Data Report. Bethesda MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1993; March.Google Scholar
- 5.Basadonna G, Matas AJ, Gillingham K, Sutherland DE, Payne WD, Dunn Dl, Gores PF, Gruessner RW, Arrazola I, Najarian JS. »Kidney transplantation in patients with type I diabetes: 26-year experience at the University of Minnesota.« In Clinical Transplants 1992. Terasaki PI, Cecka JM, eds. Los Angeles, CA: UCLA Tissue Typing Laboratory, 1993; pp 227–235.Google Scholar
- 7.Nagai N. Clinical statistics of 551 patients with diabetes mellitus found before 30 years of age. J Tokyo Worn Med Coll 1982; 52: 904–915.Google Scholar
- 11.Balodimus MC. »Diabetic nephropathy.« In Joslin’s Diabetes. Marble A, White P, Bradley RF, Krall LP, eds. Philadelphia: Lea and Febiger, 1971; pp 526–561.Google Scholar
- 17.Rettig RA, Levinsky NG (ed). Kidney Failure and the Federal Government Access to Kidney Transplantation. Institute for Medicine (U.S.). National Academy of Sciences, 1991; pp 167-186.Google Scholar
- 18.Cecka JM, Terasaki PI. »The UNOS Scientific Renal Transplant Registry — 1991.« In Clinical Transplants 1991. Terasaki PI, ed. Los Angeles CA: UCLA Tissue Typing Laboratory, 1992; pp 1–11.Google Scholar
- 24.Brownlee M. Glycosylation of proteins and microangiopathy. Hosp Pract (Off) 1992; 27: Suppl. 1: 46–50.Google Scholar
- 34.Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML, et al. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 1993; 42: 221–232.PubMedCrossRefGoogle Scholar
- 38.Braun WE, Phillips D, Vidt DG, et al. The course of coronary artery disease in diabetics with and without renal allografts. Transplant Proc 1983; 15: 1114–1119.Google Scholar
- 46.Yuge J, Cecka JM. »Sex and age effects in renal transplantation.« In Clinical Transplants 1991. Terasaki PI, ed. Los Angeles, CA: UCLA Tissue Typing Laboratory, 1992; pp 261.Google Scholar
- 53.Shapiro R, Jordan ML, Scantlebury VP, Fung JJ, Jensen C, Vivas C, McCauley J, Irish WD, Mitchell S, Demetrias AJ et al. Randomized trial of FK 506/prednisone vs FK 50-6/azathioprine/prednisone after renal transplantation: preliminary report. Transplant Proc 1993; 25: 669–672.PubMedCentralPubMedGoogle Scholar